Novo Nordisk (NVO) Cash US GAAP (year values)

2021 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Cash 17 485 000 000 17 485 000 000 23 574 000 000 23 574 000 000 30 230 000 000   74 881 000 000  
Changes by years, y/y, % +37% 0% +35% 0% +28%     +14.1%

Novo Nordisk. Cash

Novo Nordisk. Cash, changes, %

Novo Nordisk (NVO) Cash US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Cash 47 595 000 000 30 230 000 000 9 303 000 000 62 654 000 000 74 881 000 000   74 881 000 000
Changes by years, y/y, % +27% +28% -67% +72% +57%    
Changes by quarters, q/q, % +31% -36% -69% +573% +20%    

Novo Nordisk. Cash

Novo Nordisk. Cash, changes, y/y, %

Novo Nordisk. Cash, changes, q/q, %